John Okombo

About John Okombo

John Okombo, With an exceptional h-index of 22 and a recent h-index of 17 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of Medicinal Chemistry.

His recent articles reflect a diverse array of research interests and contributions to the field:

Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum

Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target

Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum, and Synergize with Clinical …

Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual …

The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance

Prioritization of molecular targets for antimalarial drug discovery

John Okombo Information

University

Position

PostDoc

Citations(all)

1346

Citations(since 2020)

926

Cited By

777

hIndex(all)

22

hIndex(since 2020)

17

i10Index(all)

36

i10Index(since 2020)

28

Email

University Profile Page

Google Scholar

John Okombo Skills & Research Interests

Medicinal Chemistry

Top articles of John Okombo

Additional PfCRT mutations driven by selective pressure for improved fitness can result in the loss of piperaquine resistance and altered Plasmodium falciparum physiology

Mbio

2024/1/16

Advances in malaria pharmacology and the online guide to MALARIA PHARMACOLOGY: IUPHAR review 38

2023/8

Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum

Nature Communications

2023/5/27

Cytoplasmic isoleucyl tRNA synthetase as an attractive multistage antimalarial drug target

Science translational medicine

2023/3/8

Pyrido-Dibemequine Metabolites Exhibit Improved Druglike Features, Inhibit Hemozoin Formation in Plasmodium falciparum, and Synergize with Clinical …

ACS Infectious Diseases

2023/2/20

John Okombo
John Okombo

H-Index: 14

Timothy J Egan
Timothy J Egan

H-Index: 31

Piperaquine-resistant PfCRT mutations differentially impact drug transport, hemoglobin catabolism and parasite physiology in Plasmodium falciparum asexual …

PLoS pathogens

2022/10/28

The Plasmodium falciparum ABC transporter ABCI3 confers parasite strain-dependent pleiotropic antimalarial drug resistance

Cell chemical biology

2022/5/19

Prioritization of molecular targets for antimalarial drug discovery

ACS infectious diseases

2021/9/15

Genomic and genetic approaches to studying antimalarial drug resistance and Plasmodium biology

2021/6/1

John Okombo
John Okombo

H-Index: 14

3-Hydroxy-propanamidines, a new class of orally active antimalarials targeting Plasmodium falciparum

Journal of medicinal chemistry

2021/3/5

Novel Antimalarial Tetrazoles and Amides Active against the Hemoglobin Degradation Pathway in Plasmodium falciparum

Journal of medicinal chemistry

2021/2/23

Correction to “Identification of 2, 4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and In Vivo Efficacy in the Plasmodium …

Journal of Medicinal Chemistry

2021/1/28

Identification of 2, 4-disubstituted imidazopyridines as hemozoin formation inhibitors with fast-killing kinetics and in vivo efficacy in the Plasmodium falciparum NSG mouse model

Journal of medicinal chemistry

2020/10/26

Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility

Nature Communications

2020/9/23

Structure-activity relationship analyses of fusidic acid derivatives highlight crucial role of the C-21 carboxylic acid moiety to its anti-mycobacterial activity

Bioorganic & Medicinal Chemistry

2020/7/1

John Okombo
John Okombo

H-Index: 14

Pyronaridine-artesunate Shows Promise as an Effective and Well-tolerated Treatment for Artemisinin-resistant Plasmodium falciparum Malaria

2020/5/6

John Okombo
John Okombo

H-Index: 14

Pharmacokinetics and organ distribution of C-3 alkyl esters as potential antimycobacterial prodrugs of fusidic acid

ACS infectious diseases

2020/2/3

Natasha Strydom
Natasha Strydom

H-Index: 4

John Okombo
John Okombo

H-Index: 14

Plasmepsin inhibitors in antimalarial drug discovery: medicinal chemistry and target validation (2000 to present)

Journal of medicinal chemistry

2020/1/8

John Okombo
John Okombo

H-Index: 14

See List of Professors in John Okombo University(Columbia University in the City of New York)